Sensus Blog

The future of skin cancer treatment is now. Stay ahead of the curve with our library of informational blogs.

April
27
2026

Basal Cell Carcinoma vs. Squamous Cell Carcinoma: What’s the Difference?

Melanoma and non-melanoma are two primary categories of skin cancer. Each presents different symptoms and treatment options. Within the non-melanoma skin cancer – sometimes referred to as NMSC – category, the two most common types…

June
10
2016

Sensus Healthcare Rings the Opening Bell at the Nasdaq MarketSite

Sensus Healthcare participated in an opening bell ringing ceremony at the Nasdaq MarketSite on Thursday, June 9, 2016. With important employees, partners and families on hand, Sensus Healthcare’s Chief Executive Officer, Joseph Sardano, officially opened…

June
08
2016

Sensus Healthcare, Inc. Announces Completion of Initial Public Offering, including Underwriters’ Exercise of Over-Allotment Option in Full

BOCA RATON, Fla., June 8, 2016 — Sensus Healthcare, Inc. (NASDAQ: SRTSU), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy,…

June
06
2016

ASDS: Skin Cancer Treatments Among Most Frequently Performed Procedures in 2015

Dermatologic surgeons performed nearly 10 million medical and cosmetic procedures in 2015 – up five percent since 2014 and 27 percent since 2012, according to the 2015 American Society for Dermatologic Surgery (ASDS) Survey on Dermatologic Procedures….

May
22
2016

2nd Annual American Cutaneous Oncology Society: SRT Best Practices Conference 2016 Recap Video

Archives
Archives

IN THE NEWS

CEO Joseph Sardano on Coding for Superficial Radiation Therapy